Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer
Huang‐Chiao Huang(University of Maryland, Baltimore), Tayyaba Hasan(Harvard University), Imran Rizvi(University of North Carolina at Chapel Hill), Joyce Liu(Harvard University), Ruth Goldschmidt(Weizmann Institute of Science), Neema Ebrahim-Zadeh(MGH Institute of Health Professions), Srivalleesha Mallidi(Tufts University), Zhiming Mai(MGH Institute of Health Professions), Chun-Te Chiang(National Taiwan University)
Cited by 138
Related Papers
Inorganic nanoparticles for cancer imaging and therapy
|Journal of Controlled Release|2011|599
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy
|Theranostics|2016|432
Immunological and Toxicological Considerations for the Design of Liposomes
|Nanomaterials|2020|357
Breaking the selectivity-uptake trade-off of photoimmunoconjugates with nanoliposomal irinotecan for synergistic multi-tier cancer targeting
|Journal of Nanobiotechnology|2020|327
Intracellular Drug Delivery by Poly(lactic-<i>co</i>-glycolic acid) Nanoparticles, Revisited
|Molecular Pharmaceutics|2008|231